Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553

Parkinsonism: onset, progression, and mortality

Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107

MDS clinical diagnostic criteria for Parkinson’s disease

Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders · doi:10.1002/mds.22340 · Cited by 7,536

Parkinson's disease

Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184

Overdependence on degraded gist memory in Alzheimer's disease.

Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,757

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

Tomlinson, C. L., Stowe, R. L., Patel, S., Rick, C., Gray, R. G., & Clarke, C. E. (2010) · Movement Disorders · doi:10.1002/mds.23429 · Cited by 4,219

Multiple Wearable Sensors in Parkinson and Huntington Disease Individuals: A Pilot Study in Clinic and at Home

Adams, J., Dinesh, K., Xiong, M., Tarolli, C. G., Sharma, S., Sheth, N., Aranyosi, A. J., Zhu, W. Y., Goldenthal, S. B., Biglan, K., et al. (2017) · Digital Biomarkers · doi:10.1159/000479018 · Cited by 3,190

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990

Non-motor symptoms of Parkinson's disease: diagnosis and management

Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807

Bioinformatics analysis of potential common pathogenic mechanism for carotid atherosclerosis and Parkinson’s disease

Wang, Q., & Xue, Q. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1202952 · Cited by 4

RGS10 attenuates systemic immune dysregulation induced by chronic inflammatory stress

Jernigan, J. E., Staley, H. A., Baty, Z., Bolen, M. L., Gomes, B. N., Holt, J., Cole, C. L., Neighbarger, N. K., Dheeravath, K., Merchak, A. R., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03322-1 · Cited by 4

Molecular profiling in Parkinsonian syndromes: CSF biomarkers

Paoletti, F. P., Gaetani, L., & Parnetti, L. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.002 · Cited by 5

Mutated LRRK2 induces a reactive phenotype and alters migration in human iPSC-derived pericyte-like cells

Peltonen, S., Sonninen, T.-M., Niskanen, J., Koıstınaho, J., Ruponen, M., & Lehtonen, Š. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00592-y · Cited by 4

The vicious cycle: unraveling the interplay between α-synuclein, mitochondrial dysfunction, and neuroinflammation in Parkinson’s disease

Liang, Y.-L., Yang, F.-G., & Tang, Q. (2026) · Journal of Neurology · doi:10.1007/s00415-026-13900-3 · Cited by 3

Biological Function Analysis of MicroRNAs and Proteins in the Cerebrospinal Fluid of Patients with Parkinson’s Disease

Hwang, J. S., Kim, S. G., George, N. P., Kwon, M., Jang, Y. E., Lee, S. S., & Lee, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413260 · Cited by 3

Innate Immunity and Parkinson's DiseasePreprint

Oludipe, D. B., Du, X., Akter, S., Zhang, C., Mosley, R. L., Gendelman, H. E., & Sil, S. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041640 · Cited by 3

Neuroimmune crosstalk in Parkinson’s disease: the pivotal role of microglia and infiltrating T cells

Li, X., Sun, W., Chen, W., Wang, N., & Wang, S. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11067-0 · Cited by 2

Immune and metabolic signatures characterise constipation-driven endophenotypes in Parkinson’s disease

Figliomeni, A., Winter, S. J., Abonnel, M. Y., Kenna, J. E., Lodge, S., Whiley, L., Bernal, A., Coudert, J. D., Noonan, J. E., Kaskow, B. J., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01212-8 · Cited by 3

DYRK1A and Parkinson’s disease, facts and hypotheses

Meijer, L., Lindberg, M. F., Hogrel, G., & Khor, B. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107379 · Cited by 2

Immunology and microbiome: Implications for motor systems

Mahjoub, Y., & Martino, D. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98818-6.00001-7 · Cited by 2

Disease mechanisms as subtypes: Immune dysfunction in Parkinson's disease

Contaldi, E., Magistrelli, L., & Comi, C. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00008-4 · Cited by 3

Pink1/Parkin deficiency alters circulating lymphocyte populations and increases platelet-T cell aggregates in rats

Manganaro, J. E., Emanuel, K. M., Lamberty, B. G., George, J. W., & Stauch, K. L. (2024) · Scientific Reports · doi:10.1038/s41598-024-74775-w · Cited by 2

JAK/STAT Signaling Predominates in Human and Murine Fungal Post-infectious Inflammatory Response SyndromePreprint

Hargarten, J. C., Ssebambulidde, K., Anjum, S. H., Vaughan, M. J., Xu, J., Song, B., Ganguly, A., Park, Y., Scott, T. L., Hammoud, D. A., et al. (2024) · medRxiv · doi:10.1101/2024.01.18.24301483 · Cited by 2

Rapid one-step protocol for exploring immune cells in cerebrospinal fluid

Millet-Wallisky, E., Malergue, F., Petrirena, G. J., & Boucraut, J. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578687 · Cited by 1

Constipation Is Linked to Neuroinflammation in Early Parkinson's Disease

Camacho, M., Greenland, J. C., Peattie, A. R. D., Spindler, L. R. B., Holbrook, J. A., Kahanawita, L., Fryer, T. D., Hong, Y. T., & Williams‐Gray, C. H. (2025) · Movement Disorders · doi:10.1002/mds.70102 · Cited by 1

Parkinson's disease: A chronic systemic inflammatory disorder

Khan, H., & Benskey, M. J. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-21992-4.00006-3 · Cited by 1

Therapeutic potential of Cistanche against Parkinson's disease via regulating circulating inflammation: Insights from Mendelian randomization, molecular docking, and in vivo studies

Liu, H., Chen, Y., Li, C. Y., Zhang, Q., Lin, X., Lin, Y., & Xu, Q. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113071 · Cited by 1

Cellular immunophenotyping in multiple sclerosis: advances and clinical implications

Möllenkamp, T. M., Müller‐Miny, L., & zu Hörste, G. M. (2026) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001496 · Cited by 1

Inhibiting the transient receptor potential melastatin 2 channel in microglia: current evidence and therapeutic potential in neurological disorders

Ferreira, A. F. F., Feng, Z., Sun, H., & Britto, L. R. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01797-7 · Cited by 1

Lifting the Veil on Neuroinflammation in Parkinson’s Disease: A Bibliometric Analysis

Dong, S., Li, X., Wang, S., 宫玉波, Wu, L., Hu, J., & Chen, X. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s607710 · Cited by 1

Emerging biomarkers for Parkinson's disease in biological fluids

Rožanković, P. B., & Šimić, G. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1835751 · Cited by 1

Immune response during idiopathic Parkinson's disease: From humans to animal models

Nissen, S. K., Ferreira, S. A., Klæstrup, I. H., & Romero‐Ramos, M. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.08.006 · Cited by 1

Myelin-reactive B cells exacerbate the severity of CD4 + T cell-driven CNS autoimmunity in an IL-23-dependent mannerPreprint

Fazazi, M. R., Doss, P. M. I. A., Pereira, R., Fudge, N. J., Regmi, A., Joly-Beauparlant, C., Akbar, I., Yeola, A. P., Mailhot, B., Baillargeon, J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/721696 · Cited by 1

LRRK2 G2019S mutation suppresses differentiation of Th9 and Treg cells via JAK/STAT3Preprint

Zheng, N., Jaffery, R., Guerrero, A. M., Hou, J., Pan, Y., Zhou, F., Chen, S., Xu, C., Egan, N. A., Bohat, R., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.28.582561 · Cited by 1

Integrated Stress Response Signatures Drive Monocyte Dysfunction in GBA1 - and LRRK2 -Linked Parkinson’s DiseasePreprint

Mattei, D., Brophy, E., Rosén, M., Majos, O. N., Domingo, A., Meijia, E., Sanctis, C. D., Jang, B., Khashan, T., Yang, M., et al. (2025) · medRxiv · doi:10.1101/2025.10.08.25337448 · Cited by 2

LRRK2-dependent Rab GTPase phosphorylation in response to endolysosomal damage depends on macrophage differentiationPreprint

Herbst, S., & Gutierrez, M. G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.02.323873

Single-cell RNA-seq reveals alterations in peripheral CX3CR1 and nonclassical monocytes in familial tauopathyPreprint

Sirkis, D. W., Solsberg, C. W., Johnson, T. P., Bonham, L. W., Sturm, V. E., Lee, S. E., Rankin, K. P., Rosen, H. J., Boxer, A. L., Seeley, W. W., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.28.514304

Additional file 1 of Inflammation-related gene polymorphisms associated with Parkinson’s disease: an updated meta-analysis

Ulhaq, Z. S., & Garcia, C. P. (2020) · Figshare · doi:10.6084/m9.figshare.12085158

"Recommendations for clinical study protocols for immune and inflammatory profiling in Parkinson's disease".

Muñoz‐Delgado, L., Williams‐Gray, C. H., Garraux, G., Clemente, D., Çakmak, Ö. Ö., Greenland, J. C., Figueira, I., Machín-Díaz, I., Pirovano, E., di Flora, A., et al. (2024) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

CPNE1 modulates Parkinson’s disease risk through peripheral immune cell function: a cross-tissue and single-cell causal inference study

Zhao, J., Fu, J., Zhang, J., Zhang, Z., Bai, X., & Yao, L. (2026) · Mammalian Genome · doi:10.1007/s00335-026-10236-1

Regulator of G protein signaling 10: a critical regulator of chronic systemic inflammation in parkinson’s disease

Jernigan, J. E., Menees, K. B., & Tansey, M. G. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03858-4

USP15 REGULATES NEUROINFLAMMATION AND DRIVES PATHOGENESIS IN SYNUCLEINOPATHIESPreprint

Fodil, N., del Cid‐Pellitero, E., Piscopo, V. E. C., Luo, J. X. X., Wong, M., Olivier, J.-F., Alluli, A., Shlaifer, I., You, Z., Chen, C. X. ‐., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.05.749595

Role of T cells in Parkinson’s disease

Koops, D., Lehmann, R., Bianchi, F., & van den Bogaart, G. (2026) · BMJ Immunology · doi:10.1136/bmjimm-2026-000039

Peripheral-central immune crosstalk in Parkinson’s disease and its association with clinical severity

Greenland, J. C., Holbrook, J. A., Kahanawita, L., Camacho, M., Fryer, T. D., Hong, Y. T., & Williams‐Gray, C. H. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.04.028 · Cited by 16

Abnormal subpopulations of monocytes in the cerebrospinal fluid of patients with Parkinson's disease

Pillny, C., Nitsch, L., Proske-Schmitz, S., Sharma, A., & Wüllner, U. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.02.017 · Cited by 19

Reduced Activated T Lymphocytes (CD4+CD25+) and Plasma Levels of Cytokines in Parkinson’s Disease

Rocha, N. P., Assis, F., Scalzo, P. L., Vieira, É. L. M., Barbosa, I. G., de Souza, M. S., Christo, P. P., Reis, H. J., & Teixeira, A. L. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0404-y · Cited by 70

Profiling peripheral immune cells in Parkinson's disease: A scoping review

Recinto, S. J., Jernigan, J. E., Lefter, N., Vitic, Z., Overgaard, M. O., Liu, L., Howden, A. J. M., Eyer, K., Romero‐Ramos, M., Tansey, M. G., et al. (2026) · Journal of Parkinson s Disease · doi:10.1177/1877718x261479505 · Cited by 2

Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease

Yan, Z., Yang, W., Wei, H., Dean, M. N., Standaert, D. G., Cutter, G., Benveniste, E. N., & Qin, H. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001036 · Cited by 110